Effects of acute and repeated treatment with a novel dopamine D 2 receptor ligand on l-DOPA-induced dyskinesias in MPTP monkeys

By Tahar A.H.   Ekesbo A.   Gregoire L.   Bangassoro E.   Svensson K.A.   Tedroff J.   Bedard P.J.  

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 247-254

Elsevier

Access to resources Recommend Favorite

New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

By Blandini Fabio   Armentero Marie-Therese  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 153-168

Informa Healthcare

Access to resources Recommend Favorite

Increased incidence of dyskinesias and other behavioral effects of re-exposure to neuroleptic treatment in social colonies of monkeys

By Linn Gary S.   Lifshitz Kenneth   O'Keeffe Robert T.   Lee Kai   Camp-Lifshitz Janet  

Psychopharmacology, Vol. 153, Iss. 3, 2001-01 ,pp. : 285-294

Springer Publishing Company

Access to resources Recommend Favorite

The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson’s disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram

By Kuan Wei-Li   Zhao Jing-Wei   Barker Roger  

Psychopharmacology, Vol. 197, Iss. 2, 2008-04 ,pp. : 279-293

Springer Publishing Company

Access to resources Recommend Favorite

Levodopa: Dyskinesias: case report

By  

Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. : 29-30

Adis International

Access to resources Recommend Favorite